Inhalation. Two concentrations of the test substance shall be used in this portion of the study, a low concentra- tion and a high concentration. The high concentration should ideally in- duce some overt toxicity, while the low concentration should correspond to a no observed level. Inhalation treat- ment should be conducted using a ‘‘nose-cone’’ or ‘‘head only’’ apparatus to prevent ingestion of the test sub- stance through ‘‘grooming’’.
Inhalation. T wo co n ce n t r a t io n s of t h e t es t s u bs t a n ce s h a ll be u sed i n t h i s po r t io n of t h e s t u d y , a low co n ce n t r a- t io n a n d a h ig h co n ce n t r a t io n . T h e h ig h co n ce n t r a t io n s h o u ld ide a ll y i n- d u ce so m e ove r t t oxici t y , w h ile t h e low co n ce n t r a t io n s h o u ld co rr espo n d t o a n o obse r ved level. I nh a l a t io n t r e a t - m e n t s h o u ld be co n d u c t ed u s i n g a ‘‘n ose- co n e’’ o r ‘‘h e a d o n l y’’ a pp a r a t u s t o p r eve n t i n ges t io n of t h e t es t s u b- s t a n ce t hr o u g h ‘‘g r oo m i n g’’.
Inhalation. May cause irritation to the respiratory tract. Symptoms may include coughing and shortness of breath. Ingestion: May cause irritation to the gastrointestinal tract, nausea, vomiting and abdominal pain. Symptoms may include headaches, blurred vision, fatigue, drowsiness and nervous system depression. CHRONIC: Repeated or prolonged exposure may cause skin rash and irritation of mucous membranes. Repeated ingestion may cause central nervous system deer ion, irritability and headache. Medical Conditions Aggravated by Exposure: Persons suffering from depression, alcoholism, neurological or psychological disorders may be more susceptible to the effects of the substance. 11F PA Rating: Health = 2: Flammability = 0: Instability = 0 (Rating is for dry material, no information on blended solution).
Inhalation. May cause irritation to the respiratory tract. Symptoms may include coughing and shortness of breath. Ingestion: May cause irritation to the gastrointestinal tract, nausea, vomiting and abdominal pain. Symptoms may include headaches, blurred vision, fatigue, drowsiness and nervous system depression. CHRONIC: Repeated or prolonged exposure may cause skin rash and irritation of mucous membranes. Repeated ingestion may cause central nervous system deer ion, irritability and headache. Medical Conditions Aggravated by Exposure: Persons suffering from depression: alcoholism: neurological or psychological disorders may be more susceptible to the effects of the substance_ NFPA Rating: Health = 2: Flammability = 0: Instability = 0 11FPA Rating: Health = 2: Flammability = 0: Instability = 0 (Rating is for dry material, no information on blended solution).
Inhalation. Immediately move to fresh air. If not breathing give artificial respiration or, if breathing is difficult, give oxygen and notify medical personnel and supervisor.
Inhalation. Personnel affected by methacrylic acid vapors must be moved at once to an uncontaminated atmosphere. another trained emergency health professional as soon as possible and transport to a suitable clinic or hospital. If breathing is difficult, trained personnel should administer oxygen.
Inhalation. Silicosis Respirable crystalline silica (quartz) can cause silicosis, a fibrosis (scarring) of the lungs. Silicosis may be progressive; it may lead to disability and death.
Inhalation. The Contractor shall not use solvent products that when inhaled causes headaches, nausea, vomiting and dizziness from contact with the solvents; and,
Inhalation. This product does not produce any harmful fumes. --------------------------------------------------------------------------------------------------------------------- FIRE HAZARDS: NON-FLAMMABLE
Inhalation i. Immediately remove the victim to clean air. Call 911, inform the emergency dispatcher of a hydrofluoric acid exposure and request emergency transport.
ii. Ensure emergency responders and treating physicians are aware of the nature of the chemical exposure. Provide a copy of the MSDS to emergency responders and request transport to Sparrow Hospital NOT Xxxx Health Center.
iii. Inhalation of hydrofluoric acid fumes may cause swelling in the respiratory tract up to 24 hours after exposure. Persons who have inhaled hydrofluoric acid vapors must be transported to the hospital immediately.
a. Container (tube) of 2.5% calcium gluconate gel. This gel is available from several suppliers. The gel must be inspected at least monthly to ensure that it is available and has not reached the expiration date. lf the gel has exceeded its shelf life or has been opened (i.e. used), a new tube must be purchased and the old container discarded.
b. Two pairs of Neoprene or Nitrile gloves.
c. Chemical safety goggles.
d. Copy of these procedures and MSDS to provide to emergency response personnel.
e. Easy-to-read emergency assistance instructions in language(s) pertinent to colleagues providing first aid to victim. The HF Exposure Kit in this laboratory can be found here:
